Alnylam Pharmaceuticals | Beneficio Operativo

Precio De Mercado
314.40
Cambio Diario
5.92 1.92%
Mensual
-14.30%
Anual
22.60%
Q1 Expectativa
304.65




Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Incyte USD 383.88M 47.43M 2025-12
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.58B 879M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.5B 2.29B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Takeda JPY 168.82B 479.89B 2025-12
Tectonic Therapeutic USD -21.89M 440K 2025-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xencor USD -47.52M 14.35M 2025-09


Alnylam Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.